Nutritional support in the pharmacological treatment of metabolic syndrome

European Journal of Pharmacology

Volumn 668, Issue SUPPL. 1, 2011, Pages

  Visioli, Francesco ^a  

^a IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Essential fatty acid; Functional food; Green tea; Metabolic syndrome; Nutraceutical; Olive oil; Polyphenol

Indexed keywords

BETA GLUCAN; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; GREEN TEA EXTRACT; HYDROXYTYROSOL; ICOSAPENTAENOIC ACID; ISPAGULA; LINOLENIC ACID; MANNAN; MEDIUM CHAIN FATTY ACID; NUTRACEUTICAL; OLEUROPEIN; OLIVE OIL; OMEGA 3 FATTY ACID; POLYPHENOL; SOYBEAN PROTEIN; TRANS FATTY ACID;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG MECHANISM; FUNCTIONAL FOOD; GUAR; HEART PROTECTION; HUMAN; METABOLIC SYNDROME X; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; TEA; TREATMENT INDICATION;

ALCOHOLIC BEVERAGES; ANIMALS; DIETARY FIBER; FATTY ACIDS; HUMANS; METABOLIC SYNDROME X; POLYPHENOLS; SOYBEAN PROTEINS;

EID: 80054992676     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.083     Document Type: Conference Paper

References (66)

1. Adult Treatment Panel III Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. M.A. Albert, R.J. Glynn, and P.M. Ridker Alcohol consumption and plasma concentration of C-reactive protein Circulation 107 2003 443 447 (Pubitemid 36158047)
3. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, and S.C. Smith Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 2009 1640 1645
4. A. Alkerwi, M. Boutsen, M. Vaillant, J. Barre, M.L. Lair, A. Albert, M. Guillaume, and M. Dramaix Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies Atherosclerosis 204 2009 624 635
5. N. Babio, M. Bullo, and J. Salas-Salvado Mediterranean diet and metabolic syndrome: the evidence Public Health Nutr. 12 2009 1607 1617
6. P. Bogani, C. Galli, M. Villa, and F. Visioli Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil Atherosclerosis 190 2007 181 186 (Pubitemid 44908313)
7. J.T. Brenna, N. Salem Jr., A.J. Sinclair, and S.C. Cunnane alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans Prostaglandins Leukot. Essent. Fatty Acids 80 2009 85 91
8. E.A. Brinton Effects of ethanol intake on lipoproteins and atherosclerosis Curr. Opin. Lipidol. 21 2010 346 351
9. L. Brown, B. Rosner, W.W. Willett, and F.M. Sacks Cholesterol-lowering effects of dietary fiber: a meta-analysis Am. J. Clin. Nutr. 69 1999 30 42 (Pubitemid 29031248)
10. Calder, P.C., 2011. Fatty acids and inflammation: the cutting edge between food & pharma. Eur. J. Pharmacol. This Issue.
11. A. Camargo, J. Ruano, J.M. Fernandez, L.D. Parnell, A. Jimenez, M. Santos-Gonzalez, C. Marin, P. Perez-Martinez, M. Uceda, J. Lopez-Miranda, and F. Perez-Jimenez Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil BMC Genomics 11 2010 253
12. R.S. Chapkin, W. Kim, J.R. Lupton, and D.N. McMurray Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation Prostaglandins Leukot. Essent. Fatty Acids 81 2009 187 191
13. M.I. Covas Olive oil and the cardiovascular system Pharmacol. Res. 55 2007 175 186
14. G.C. Descovich, C. Ceredi, A. Gaddi, M.S. Benassi, G. Mannino, L. Colombo, L. Cattin, G. Fontana, U. Senin, E. Mannarino, C. Caruzzo, E. Bertelli, C. Fragiacomo, G. Noseda, M. Sirtori, and C.R. Sirtori Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients Lancet 2 1980 709 712 (Pubitemid 10060059)
15. P. Ducimetiere Alimentation et risque coronaire. Le paradox française n'a plus lieu d'être Questions de Santé Publique 6 2009 1 4
16. J.W. Erdman Jr. AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA Circulation 102 2000 2555 2559
17. A. Esfahani, J.M. Wong, A. Mirrahimi, K. Srichaikul, D.J. Jenkins, and C.W. Kendall The glycemic index: physiological significance J. Am. Coll. Nutr. 28 Suppl 2009 439S 445S
18. M. Foltz, P. Ansems, J. Schwarz, M.C. Tasker, A. Lourbakos, and C.C. Gerhardt Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor J. Agric. Food Chem. 56 2008 837 843 (Pubitemid 351300253)
19. W. Gade, J. Schmit, M. Collins, and J. Gade Beyond obesity: the diagnosis and pathophysiology of metabolic syndrome Clin. Lab. Sci. 23 2010 51 61
20. N.A. Georgiou, J. Garssen, and R.F. Witkamp Pharma-nutrition interface: the gap is narrowing Eur. J. Pharmacol. 651 2011 1 8
21. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87 (Pubitemid 36126394)
22. S. Gorelik, M. Ligumsky, R. Kohen, and J. Kanner The stomach as a "bioreactor": when red meat meets red wine J. Agric. Food Chem. 56 2008 5002 5007 (Pubitemid 352039096)
23. D. Johansen, K. Friis, E. Skovenborg, and M. Gronbaek Food buying habits of people who buy wine or beer: cross sectional study BMJ 332 2006 519 522
24. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 23 2003 e20 e30
25. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association Arterioscler. Thromb. Vasc. Biol. 23 2003 151 152 (Pubitemid 36231919)
26. J.D. Lambert, M.J. Kennett, S. Sang, K.R. Reuhl, J. Ju, and C.S. Yang Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice Food Chem. Toxicol. 48 2010 409 416
27. C. Lavigne, A. Marette, and H. Jacques Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats Am. J. Physiol. Endocrinol. Metab. 278 2000 E491 E500
28. J.Y. Le Guennec, S. Jude, P. Besson, E. Martel, and P. Champeroux Cardioprotection by omega-3 fatty acids: involvement of PKCs? Prostaglandins Leukot. Essent. Fatty Acids 82 2010 173 177
29. B.D. Levy Resolvins and protectins: natural pharmacophores for resolution biology Prostaglandins Leukot. Essent. Fatty Acids 82 2010 327 332
30. A.H. Lichtenstein, L.J. Appel, M. Brands, M. Carnethon, S. Daniels, H.A. Franch, B. Franklin, P. Kris-Etherton, W.S. Harris, B. Howard, N. Karanja, M. Lefevre, L. Rudel, F. Sacks, L. Van Horn, M. Winston, and J. Wylie-Rosett Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee Circulation 114 2006 82 96 (Pubitemid 44305278)
31. B. Lonnerdal Soybean ferritin: implications for iron status of vegetarians Am. J. Clin. Nutr. 89 2009 1680S 1685S
32. D. Man, R. Olchawa, and K. Kubica Membrane fluidity and the surface properties of the lipid bilayer: ESR experiment and computer simulation J. Liposome Res. 20 2010 211 218
33. M. Massaro, E. Scoditti, M.A. Carluccio, and R. De Caterina Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease Prostaglandins Leukot. Essent. Fatty Acids 79 2008 109 115
34. J.C. Merritt Metabolic syndrome: soybean foods and serum lipids J. Natl. Med. Assoc. 96 2004 1032 1041 (Pubitemid 38971096)
35. O. Mezei, Y. Li, E. Mullen, J.S. Ross-Viola, and N.F. Shay Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms Physiol. Genomics 26 2006 8 14 (Pubitemid 43974218)
36. R. Micha, and D. Mozaffarian Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes Nat. Rev. Endocrinol. 5 2009 335 344
37. P.B. Mikkelsen, S. Toubro, and A. Astrup Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate Am. J. Clin. Nutr. 72 2000 1135 1141
38. A.M. Minihane Fatty acid-genotype interactions and cardiovascular risk Prostaglandins Leukot. Essent. Fatty Acids 82 2010 259 264
39. D. Mozaffarian Fish, n-3 fatty acids, and cardiovascular haemodynamics J. Cardiovasc. Med. (Hagerstown) 8 Suppl 1 2007 S23 S26
40. E. Mullen, R.M. Brown, T.F. Osborne, and N.F. Shay Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells J. Nutr. 134 2004 2942 2947 (Pubitemid 39470066)
41. K. Nagao, and T. Yanagita Medium-chain fatty acids: functional lipids for the prevention and treatment of the metabolic syndrome Pharmacol. Res. 61 2010 208 212
42. A. Nagasawa, K. Fukui, T. Funahashi, N. Maeda, I. Shimomura, S. Kihara, M. Waki, K. Takamatsu, and Y. Matsuzawa Effects of soy protein diet on the expression of adipose genes and plasma adiponectin Horm. Metab. Res. 34 2002 635 639 (Pubitemid 36398698)
43. Y. Peled, and T. Gilat Effect of dietary phospholipids and their constituents on bile composition in rats and hamsters Hepatology 19 1994 708 713 (Pubitemid 24066903)
44. A. Poli, F. Marangoni, R. Paoletti, E. Mannarino, G. Lupattelli, A. Notarbartolo, P. Aureli, F. Bernini, A. Cicero, A. Gaddi, A. Catapano, C. Cricelli, M. Gattone, W. Marrocco, M. Porrini, R. Stella, A. Vanotti, M. Volpe, R. Volpe, C. Cannella, A. Pinto, E. Del Toma, C. La Vecchia, A. Tavani, E. Manzato, G. Riccardi, C. Sirtori, and A. Zambon Non-pharmacological control of plasma cholesterol levels Nutr. Metab. Cardiovasc. Dis. 18 2008 S1 S16
45. J. Poss, F. Custodis, C. Werner, O. Weingartner, M. Bohm, and U. Laufs Cardiovascular disease and dyslipidemia: beyond LDL Curr. Pharm. Des. 17 9 2011 861 870
46. H. Poudyal, F. Campbell, and L. Brown Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats J. Nutr. 140 2010 946 953
47. G.M. Reaven The metabolic syndrome: time to get off the merry-go-round? J. Intern. Med. 269 2011 127 136
48. D. Richard, K. Kefi, U. Barbe, P. Bausero, and F. Visioli Polyunsaturated fatty acids as antioxidants Pharmacol. Res. 57 2008 451 455
49. D. Richard, P. Bausero, C. Schneider, and F. Visioli Polyunsaturated fatty acids and cardiovascular disease Cell. Mol. Life Sci. 66 2009 3277 3288
50. D. Richard, K. Kefi, U. Barbe, A. Poli, P. Bausero, and F. Visioli Weight and plasma lipid control by decaffeinated green tea Pharmacol. Res. 59 2009 351 354
51. D. Richard, C. Wolf, U. Barbe, K. Kefi, P. Bausero, and F. Visioli Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway Biochem. Biophys. Res. Commun. 389 2009 516 522
52. R.S. Rosenson, and M.H. Gelb Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes Curr. Cardiol. Rep. 11 2009 445 451
53. S. Sae-Tan, K.A. Grove, and J.D. Lambert Laboratory studies on weight control and prevention of metabolic syndrome by green tea Pharmacol. Res. 64 2 2011 146 154
54. J. Salas-Salvado, J. Fernandez-Ballart, E. Ros, M.A. Martinez-Gonzalez, M. Fito, R. Estruch, D. Corella, M. Fiol, E. Gomez-Gracia, F. Aros, G. Flores, J. Lapetra, R. Lamuela-Raventos, V. Ruiz-Gutierrez, M. Bullo, J. Basora, and M.I. Covas Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial Arch. Intern. Med. 168 2008 2449 2458
55. C.R. Sirtori, C. Zucchi-Dentone, M. Sirtori, E. Gatti, G.C. Descovich, A. Gaddi, L. Cattin, P.G. Da Col, U. Senin, and E. Mannarino Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients Ann. Nutr. Metab. 29 1985 348 357 (Pubitemid 16243377)
56. G.J. Soleas, E.P. Diamandis, and D.M. Goldberg Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30 1997 91 113 (Pubitemid 27180922)
57. M. Studer, M. Briel, B. Leimenstoll, T.R. Glass, and H.C. Bucher Effect of different antilipidemic agents and diets on mortality: a systematic review Arch. Intern. Med. 165 2005 725 730 (Pubitemid 40569423)
58. K. Szkudelska, L. Nogowski, and T. Szkudelski Genistein affects lipogenesis and lipolysis in isolated rat adipocytes J. Steroid Biochem. Mol. Biol. 75 2000 265 271 (Pubitemid 32244256)
59. N.R. Teixeira Damasceno, E. Apolinario, F.F. Dias, I. Fernandes, and D.S. Abdalla Soy isoflavones reduce electronegative low-density lipoprotein (LDL(-)) and anti-LDL (-) autoantibodies in experimental atherosclerosis Eur. J. Nutr. 46 2007 125 132 (Pubitemid 46481363)
60. J. Tolstrup, and M. Gronbaek Alcohol and atherosclerosis: recent insights Curr. Atheroscler. Rep. 9 2007 116 124 (Pubitemid 47376982)
61. F. Visioli, and E. Bernardini Extra virgin olive oil's polyphenols: biological activities Curr. Pharm. Des. 17 8 2011 786 804
62. F. Visioli, and C. Galli Biological properties of olive oil phytochemicals Crit. Rev. Food Sci. Nutr. 42 2002 209 221
63. F. Visioli, A. Poli, and R. Paoletti Nutritional intervention helps pharmacology in the management of the metabolic syndrome Med. J. Nutr. Metabol. 3 2010 203 207
64. D. Weghuber, and K. Widhalm Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet Br. J. Nutr. 99 2008 281 286
65. S.Z. Xu, W. Zhong, M. Ghavideldarestani, R. Saurabh, S.W. Lindow, and S.L. Atkin Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury Free Radic. Biol. Med. 47 2009 167 175
66. J.M. Ye, P.J. Doyle, M.A. Iglesias, D.G. Watson, G.J. Cooney, and E.W. Kraegen Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation Diabetes 50 2001 411 417 (Pubitemid 32127300)